KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME

  • G.S. Starodub State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
  • N.V. Goryainova State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
  • T.P. Perekhrestenko State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
  • O.V. Basova State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
  • N.M. Tretiak State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
  • A.I. Gordiienko State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
DOI: https://doi.org/10.32345/USMYJ.2(95)().2016.5-8

Анотація

Patients with MDS RAEB II were examined. The decrease in dynamics of intracellular K³-67 protein expression was determined in patients with MDS RAEB II with positive response to chemotherapy, and the increase in proliferative activity of haematopoietic cells of peripheral blood (PB) and bone marrow (BM) was determined in patients with MDS RAEB II in transformation and acute myeloid leukaemia (AML) after MDS.

Опубліковано
2016-04-29
Як цитувати
Starodub, G., Goryainova, N., Perekhrestenko, T., Basova, O., Tretiak, N., & Gordiienko, A. (2016). KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME. Український науково-медичний молодіжний журнал, (2(95), 5-8. https://doi.org/10.32345/USMYJ.2(95)().2016.5-8
Номер
№ 2(95) (2016): Український науково-медичний молодіжний журнал
Розділ
Медицина
Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.